KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Debt (2016 - 2024)

Exact Sciences (EXAS) has disclosed Total Debt for 15 consecutive years, with $50.0 million as the latest value for Q1 2024.

  • On a quarterly basis, Total Debt changed 0.0% to $50.0 million in Q1 2024 year-over-year; TTM through Mar 2024 was $50.0 million, a 0.0% change, with the full-year FY2023 number at $50.0 million, changed 0.0% from a year prior.
  • Total Debt was $50.0 million for Q1 2024 at Exact Sciences, roughly flat from $50.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $50.0 million in Q2 2022 to a low of $21.4 million in Q3 2021.
  • A 5-year average of $38.1 million and a median of $50.0 million in 2022 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: plummeted 93.17% in 2020, then soared 133.23% in 2022.
  • Exact Sciences' Total Debt stood at $22.3 million in 2020, then dropped by 4.05% to $21.4 million in 2021, then skyrocketed by 133.23% to $50.0 million in 2022, then changed by 0.0% to $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024.
  • Per Business Quant, the three most recent readings for EXAS's Total Debt are $50.0 million (Q1 2024), $50.0 million (Q4 2023), and $50.0 million (Q3 2023).